Results 1 to 10 of about 70,782 (340)

Immunophenotyping of pulmonary sarcomatoid carcinoma

open access: yesFrontiers in Immunology, 2022
Background Previous studies have suggested that patients with pulmonary sarcomatoid carcinoma (PSC)may benefit from immune checkpoint inhibitors (ICIs); however, relevant data are lacking.
Yu Ma   +6 more
semanticscholar   +4 more sources

Advanced immunophenotyping: A powerful tool for immune profiling, drug screening, and a personalized treatment approach

open access: yesFrontiers in Immunology, 2023
Various autoimmune diseases are characterized by distinct cell subset distributions and activation profiles of peripheral blood mononuclear cells (PBMCs). PBMCs can therefore serve as an ideal biomarker material, which is easily accessible and allows for
Teresa Preglej   +5 more
doaj   +2 more sources

Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping Consortium [PDF]

open access: yesScientific Reports, 2016
Standardization of immunophenotyping requires careful attention to reagents, sample handling, instrument setup, and data analysis, and is essential for successful cross-study and cross-center comparison of data. Experts developed five standardized, eight-
Greg Finak   +34 more
semanticscholar   +5 more sources

Immunophenotyping beyond the limits of time

open access: yesCell Reports: Methods, 2023
Immunophenotyping is a powerful approach for deciphering responses of the immune system to drug screening and immunotherapy. In this issue of Cell Report Methods, Liechti et al.
J. Fréderique de Graaf, Ramon Arens
doaj   +3 more sources

Microglia immunophenotyping in gliomas

open access: yesOncology Letters, 2017
Microglia, once assimilated to peripheral macrophages, in gliomas has long been discussed and currently it is hypothesized to play a pro-tumor role in tumor progression.
L. Annovazzi   +5 more
semanticscholar   +5 more sources

Application and interpretation of immunophenotyping data in safety and risk assessment [PDF]

open access: yesFrontiers in Toxicology
The use of immunophenotyping during immunotoxicity investigations was first popularized in the 1980 s and has since become more integrated into diagnostic and non-clinical assessments.
Victor J. Johnson   +7 more
doaj   +2 more sources

Carboxypeptidase A3—A Key Component of the Protease Phenotype of Mast Cells

open access: yesCells, 2022
Carboxypeptidase A3 (CPA3) is a specific mast cell (MC) protease with variable expression. This protease is one of the preformed components of the secretome.
Dmitri Atiakshin   +5 more
doaj   +1 more source

Mast Cells in Regeneration of the Skin in Burn Wound with Special Emphasis on Molecular Hydrogen Effect

open access: yesPharmaceuticals, 2023
The mechanisms of regeneration for the fibrous component of the connective tissue of the dermis are still insufficiently studied. The aim of this study was to evaluate the effectiveness of the use of molecular hydrogen on the local therapy of a II degree
Dmitri Atiakshin   +8 more
doaj   +1 more source

Mast Cells as a Potential Target of Molecular Hydrogen in Regulating the Local Tissue Microenvironment

open access: yesPharmaceuticals, 2023
Knowledge of the biological effects of molecular hydrogen (H2), hydrogen gas, is constantly advancing, giving a reason for the optimism in several healthcare practitioners regarding the management of multiple diseases, including socially significant ones
Dmitri Atiakshin   +8 more
doaj   +1 more source

Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment

open access: yesFrontiers in Cell and Developmental Biology, 2021
Background: The tumor microenvironment affects the occurrence and development of cancers, including clear cell renal cell carcinoma (ccRCC). However, how the immune contexture interacts with the cancer phenotype remains unclear.
Wenhao Xu   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy